SAN DIEGO, March 27, 2017 /PRNewswire/ -- Mesa Biotech, Inc., a privately-held, molecular diagnostic company that has developed an affordable, sample-to-answer, PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) settings, today announced the appointment of two key executives to its management team. Effective immediately, Bruce Car, an accomplished medical device industry veteran, joins Mesa Biotech as Vice President of Manufacturing and Operations, and Dr. Salvatore J. Salamone, an experienced life science executive, joins as Vice President of Research & Development. "We are very pleased to welcome Bruce and Sal to the Mesa Biotech team," said Hong Cai, Co-founder and Chief Executive Officer. "Bruce brings a wealth of experience in manufacturing and operations, and Sal has a proven track record of leading research and development teams. Their combined expertise will be invaluable as we continue to grow our company and advance our innovative molecular diagnostic platform." Mr. Car has over 25 years of experience in the medical device industry. Prior to joining Mesa Biotech, he served as Vice President of Operations at AltheaDx, where he was responsible for all aspects of manufacturing, facilities, and quality. Before AltheaDx, Mr. Car held senior management positions at several other medical device companies, including GenMark Diagnostics, Inc., and Biosite, Inc. Dr. Salamone has over 20 years of experience in the life science industry. Prior to joining Mesa Biotech, he served as Vice President of Research & Development at AltheaDx. Before AltheaDx, Dr. Salamone held senior management positions at several other life science companies, including Gen-Probe Incorporated, and Applied Biosystems. About Mesa Biotech, Inc. Mesa Biotech is developing and commercializing a PCR (polymerase chain reaction) based, molecular diagnostic testing platform designed specifically for point-of-care (POC) settings. This affordable, sample-to-answer, disposable cartridge-based system provides faster results compared to other infectious disease tests, and allows testing outside of the central laboratory. The company's first test will be for Flu A/Flu B. Mesa Biotech is headquartered in San Diego, California. SOURCE Mesa Biotech, Inc.